A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 2, 2014, Pages 335-345

  Cavin, Sabrina ^a   Maric, Darko ^a   Diviani, Dario ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

A kinase anchoring protein (AKAP); Cardiac fibroblast; G protein coupled receptor; Protein kinase A; RhoA

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; COLLAGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SHORT HAIRPIN RNA;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; FIBROBLAST; GENE ACTIVATION; GENE REPRESSION; HEART MUSCLE CELL; INTRACELLULAR SIGNALING; LENTIVIRINAE; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT;

A KINASE-ANCHORING PROTEIN (AKAP); A-KINASE ANCHORING PROTEIN; ADULT VENTRICULAR FIBROBLAST; AKAP; ANG II; ANGIOTENSIN II; AT(1)RS; AVF; CARDIAC FIBROBLAST; ECM; EXTRACELLULAR MATRIX; G PROTEIN-COUPLED RECEPTOR; GEF; GTP; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATE; MRTF; MYOCARDIN RELATED TRANSCRIPTION FACTOR; NEONATAL VENTRICULAR MYOCYTE; NVM; PROTEIN KINASE A; RHOA; SH; SHORT HAIRPIN; TGF-Β; TRANSFORMING GROWTH FACTOR Β; TYPE I ANGIOTENSIN II RECEPTORS; Α-SMA; Α-SMOOTH MUSCLE ACTIN; Α1-ADRENERGIC RECEPTORS; Α1-ARS;

A KINASE ANCHOR PROTEINS; ACTINS; ANGIOTENSIN II; ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; COLLAGEN; ENZYME ACTIVATION; FIBROBLASTS; FIBROSIS; GENE SILENCING; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; HEART VENTRICLES; MODELS, BIOLOGICAL; MYOFIBROBLASTS; PHENOTYPE; RATS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84890203196     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.11.008     Document Type: Article

References (43)

1. Souders C.A., Bowers S.L., Baudino T.A. Cardiac fibroblast: the renaissance cell. Circ. Res. 2009, 105:1164-1176.
2. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu. Rev. Pharmacol. Toxicol. 2005, 245:657-687.
3. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123:255-278.
4. Petrov V.V., Fagard R.H., Lijnen P.J. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002, 39:258-263.
5. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 2000, 52:415-472.
6. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 2004, 63:423-432.
7. Porter K.E., Turner N.A., O'Regan D.J., Balmforth A.J., Ball S.G. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovasc. Res. 2004, 2004(61):745-755.
8. Zhao X.H., Laschinger C., Arora P., Szaszi K., Kapus A., McCulloch C.A. Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway. J. Cell Sci. 2007, 120:1801-1809.
9. Small E.M., Thatcher J.E., Sutherland L.B., Kinoshita H., Gerard R.D., Richardson J.A., Dimaio J.M., Sadek H., Kuwahara K., Olson E.N. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ. Res. 2010, 107:294-304.
10. Crider B.J., Risinger G.M., Haaksma C.J., Howard E.W., Tomasek J.J. Myocardin-related transcription factors A and B are key regulators of TGF-1-induced fibroblast to myofibroblast differentiation. J. Invest. Dermatol. 2011, 131:2378-2385.
11. Turner N.A., Aley P.K., Hall K.T., Warburton P., Galloway S., Midgley L., O'Regan D.J., Wood I.C., Ball S.G., Porter K.E. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. J. Mol. Cell. Cardiol. 2007, 43:168-176.
12. Rikitake Y., Oyama N., Wang C.Y., Noma K., Satoh M., Kim H.H., Liao J.K. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice. Circulation 2005, 112:2959-2965.
13. Zhang Y.M., Bo J., Taffet G.E., Chang J., Shi J., Reddy A.K., Michael L.H., Schneider M.D., Entman M.L., Schwartz R.J., et al. Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis. FASEB J. 2006, 20:916-925.
14. Diviani D., Soderling J., Scott J.D. AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation. J. Biol. Chem. 2001, 276:44247-44257.
15. Appert-Collin A., Cotecchia S., Nenniger-Tosato M., Pedrazzini T., Diviani D. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10140-10145.
16. Del Vescovo C.D., Cotecchia S., Diviani D. AKAP-Lbc anchors IKKbeta to support interleukin-6-mediated cardiomyocyte hypertrophy. Mol. Biol. Cell 2013, 33:14-27.
17. Rossini A., Zacheo A., Mocini D., Totta P., Facchiano A., Castoldi R., Sordini P., Pompilio G., Abeni D., Capogrossi M.C., et al. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. J. Mol. Cell. Cardiol. 2008, 44:683-693.
18. Snead A.N., Insel P.A. Defining the cellular repertoire of GPCRs identifies a profibrotic role for the most highly expressed receptor, protease-activated receptor 1, in cardiac fibroblasts. FASEB J. 2012, 26:4540-4547.
19. Kawano H., Do Y.S., Kawano Y., Starnes V., Barr M., Law R.E., Hsueh W.A. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 2000, 101:1130-1137.
20. Fujii T., Onohara N., Maruyama Y., Tanabe S., Kobayashi H., Fukutomi M., Nagamatsu Y., Nishihara N., Inoue R., Sumimoto H., et al. Galpha12/13-mediated production of reactive oxygen species is critical for angiotensin receptor-induced NFAT activation in cardiac fibroblasts. J. Biol. Chem. 2005, 280:23041-23047.
21. Nishida M., Onohara N., Sato Y., Suda R., Ogushi M., Tanabe S., Inoue R., Mori Y., Kurose H. Galpha12/13-mediated up-regulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation. J. Biol. Chem. 2007, 282:23117-23128.
22. Chen K., Mehta J.L., Li D., Joseph L., Joseph J. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ. Res. 2004, 95:1167-1173.
23. Carnegie G.K., Smith F.D., McConnachie G., Langeberg L.K., Scott J.D. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol. Cell 2004, 15:889-899.
24. Smith F.D., Langeberg L.K., Cellurale C., Pawson T., Morrison D.K., Davis R.J., Scott J.D. AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade. Nat. Cell Biol. 2010, 12:1242-1249.
25. Cariolato L., Cavin S., Diviani D. A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in α1-adrenergic receptor-induced p38 activation. J. Biol. Chem. 2011, 286:7925-7937.
26. Perez Lopez I., Cariolato L., Maric D., Gillet L., Abriel H., Diviani D. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy. Mol. Cell. Biol. 2013, 33:2903-2917.
27. Burmeister B.T., Taglieri D.M., Wang L., Carnegie G.K. Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart. J. Biol. Chem. 2012, 287:40535-40546.
28. Gold M.G., Lygren B., Dokurno P., Hoshi N., McConnachie G., Tasken K., Carlson C.R., Scott J.D., Barford D. Molecular basis of AKAP specificity for PKA regulatory subunits. Mol. Cell 2006, 24:383-395.
29. Diviani D., Abuin L., Cotecchia S., Pansier L. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. EMBO J. 2004, 23:2811-2820.
30. Jin J., Smith F.D., Stark C., Wells C.D., Fawcett J.P., Kulkarni S., Metalnikov P., O'Donnell P., Taylor P., Taylor L., Zougman A., Woodgett J.R., Langeberg L.K., Scott J.D., Pawson T. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr. Biol. 2004, 14:1436-1450.
31. Matsubara H., Kanasaki M., Murasawa S., Tsukaguchi Y., Nio Y., Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J. Clin. Invest. 1994, 93:1592-1601.
32. Baisamy L., Jurisch N., Diviani D. Leucine zipper-mediated homo-oligomerization regulates the Rho-GEF activity of AKAP-Lbc. J. Biol. Chem. 2005, 280:15405-15412.
33. Guilluy C., Bregeon J., Toumaniantz G., Rolli-Derkinderen M., Retailleau K., Loufrani L., Henrion D., Scalbert E., Bril A., Torres R.M., et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat. Med. 2010, 16:183-190.
34. Ying Z., Yue P., Xu X., Zhong M., Sun Q., Mikolaj M., Wang A., Brook R.D., Chen L.C., Rajagopalan S. Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1540-H1550.
35. Hilgers R.H., Todd J., Webb R.C. Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J. Hypertens. 2007, 25:1687-1697.
36. Wirth A., Benyo Z., Lukasova M., Leutgeb B., Wettschureck N., Gorbey S., Orsy P., Horváth B., Maser-Gluth C., Greiner E., et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat. Med. 2008, 14:64-68.
37. Chen J., Mehta J.L. Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1738-H1745.
38. Davis J., Burr A.R., Davis G.F., Birnbaumer L., Molkentin J.D. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev. Cell 2012, 23:705-715.
39. Tsapara A., Luthert P., Greenwood J., Hill C.S., Matter K., Balda M.S. The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration. Mol. Biol. Cell 2010, 21:860-870.
40. Phrommintikul A., Tran L., Kompa A., Wang B., Adrahtas A., Cantwell D., Kelly D.J., Krum H. Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1804-H1814.
41. Itoh Y., Kimoto K., Imaizumi M., Nakatsuka K. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. Exp. Eye Res. 2007, 84:464-472.
42. Carnegie G.K., Soughayer J., Smith F.D., Pedroja B.S., Zhang F., Diviani D., Bristow M.R., Kunkel M.T., Newton A.C., Langeberg L.K., Scott J.D. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol. Cell 2008, 32:169-179.
43. Scott J.D., Santana L.F. A-kinase anchoring proteins: getting to the heart of the matter. Circulation 2010, 121:1264-1271.